Presentation given during a Merqurio.it webinar 26 March 2021. Outlines the implications of covid-disrupted medical society conferences for the Italian pharma industry and the pharma industry in general: likely conference formats 2021; emerging formats 2022 and beyond; % Italian doctors attending major events; hybrid complexity from a pharma perspective; 4 key pharma survival strategies.